Last reviewed · How we verify

NCT04070950: FECAPSE

Sexuality of Women With Pelvic Cancer

Completed Last updated 28 August 2019
What this trial tests

trial testing Questionnaires in Sexual Behavior in 40 participants. Completed in 20 May 2010.

Timeline
1 September 2009
Primary endpoint
20 May 2010
20 May 2010

Quick facts

Lead sponsorUniversity Hospital, Bordeaux
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date1 September 2009
Primary completion20 May 2010
Estimated completion20 May 2010

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, female only, with Sexual Behavior or Pelvic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to study in patients with cancer of the cervix or the body of the uterus, or the ovary between the time of diagnosis and 3 months after the end of the last treatment: the evolution of the relationship of couple, and more particularly of communication (verbal and non-verbal) concerning sexuality, before and during cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other recruiting trials for Sexual Behavior

Currently open trials in the same condition.

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04070950.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing